Prescribing data for lecanemab features a boxed warning about probable threats associated with ARIA. Suitable use recommendations go over approaches to reduce ARIA chance, as does AAN steering. No new basic safety indicators ended up noticed with continued lecanemab treatment. Soon after the 1st six months, ARIA premiums were being https://andreii431oam3.buyoutblog.com/profile